{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:35Z","timestamp":1776329855104,"version":"3.50.1"},"reference-count":19,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.6002\/ect.2017.0231","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T09:09:33Z","timestamp":1522919373000},"page":"123-127","source":"Crossref","is-referenced-by-count":4,"title":["Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective Prophylaxis"],"prefix":"10.6002","volume":"18","author":[{"given":"Annalisa","family":"Boscolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Menin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Zelaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Albertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Zanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Baratto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"issue":"1","key":"ref0","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00007890-200301150-00022","article-title":"Liver transplant-associated graft-versus-host disease","volume":"75","author":"Smith","year":"2003","unstructured":"1. Smith DM, Agura E, Netto G, et al. Liver transplant-associated graft-versus-host disease. Transplantation. 2003;75(1):118-126.","journal-title":"Transplantation"},{"issue":"12","key":"ref1","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1097\/TP.0000000000001406","article-title":"Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management","volume":"100","author":"Murali","year":"2016","unstructured":"2. Murali AR, Chandra S, Stewart Z, et al. Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management. Transplantation. 2016;100(12):2661-2670.","journal-title":"Transplantation"},{"issue":"12","key":"ref2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/ctr.12627","article-title":"Graft-versus-host disease after orthotopic liver transplantation: multivariate analysis of risk factors","volume":"29","author":"Elfeki","year":"2015","unstructured":"3. Elfeki MA, Pungpapong S, Genco PV, Nakhleh RE, Nguyen JH, Harnois DM. Graft-versus-host disease after orthotopic liver transplantation: multivariate analysis of risk factors. Clin Transplant. 2015;29(12):1063-1066.","journal-title":"Clin Transplant"},{"key":"ref3","unstructured":"4. Matsukuma KE, Wei D, Sun K, Ramsamooj R, Chen M. Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD). J Gastrointest Oncol. 2016;7(Suppl 1):S21-31."},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/lt.21704","article-title":"Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors","volume":"15","author":"Thin","year":"2009","unstructured":"5. Thin L, Macquillan G, Adams L, et al. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors. Liver Transpl. 2009;15(4):421-426.","journal-title":"Liver Transpl"},{"issue":"7","key":"ref5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/lt.21793","article-title":"Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report","volume":"15","author":"Piton","year":"2009","unstructured":"6. Piton G, Larosa F, Minello A, et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report. Liver Transpl. 2009;15(7):682-685.","journal-title":"Liver Transpl"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.6002\/ect.2012.0083","article-title":"Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-alpha","volume":"11","author":"Blank","year":"2013","unstructured":"7. Blank G, Li J, Kratt T, Handgretinger R, Konigsrainer A, Nadalin S. Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-alpha. Exp Clin Transplant. 2013;11(1):68-71.","journal-title":"Exp Clin Transplant"},{"issue":"7","key":"ref7","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.transproceed.2014.06.061","article-title":"Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report","volume":"46","author":"Elfeki","year":"2014","unstructured":"8. Elfeki MA, Genco PV, Pungpapong S, Nakhleh RE, Nguyen JH, Harnois DM. Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report. Transplant Proc. 2014;46(7):2422-2425.","journal-title":"Transplant Proc"},{"issue":"3","key":"ref8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","article-title":"Tumor necrosis factor-alpha blockade for the treatment of acute GVHD","volume":"104","author":"Couriel","year":"2004","unstructured":"9. Couriel D, Saliba R, Hicks K, et al. Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood. 2004;104(3):649-654.","journal-title":"Blood"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.bmt.1703094","article-title":"Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human\/mouse antiTNFalpha antibody","volume":"28","author":"Kobbe","year":"2001","unstructured":"10. Kobbe G, Schneider P, Rohr U, et al. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human\/mouse antiTNFalpha antibody. Bone Marrow Transplant. 2001;28(1):47-49.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"ref10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/01.TP.0000103721.29729.FE","article-title":"Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation","volume":"77","author":"Taylor","year":"2004","unstructured":"11. Taylor AL, Gibbs P, Sudhindran S, et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation. 2004;77(3):441-446.","journal-title":"Transplantation"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/lt.21082","article-title":"-host disease in liver transplant patients","volume":"13","author":"Chan","year":"2007","unstructured":"12. Chan EY, Larson AM, Gernsheimer TB, et al. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients. Liver Transpl. 2007;13(4):516-522.","journal-title":"Liver Transpl"},{"issue":"17","key":"ref12","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.4254\/wjh.v7.i17.2080","article-title":"Immunology of hepatocellular carcinoma","volume":"7","author":"Sachdeva","year":"2015","unstructured":"13. Sachdeva M, Chawla YK, Arora SK. Immunology of hepatocellular carcinoma. World J Hepatol. 2015;7(17):2080-2090.","journal-title":"World J Hepatol"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.14701\/kjhbps.2016.20.1.38","article-title":"Successful salvage treatment of acute graft-versus-host disease after liver transplantation by withdrawal of immunosuppression: a case report","volume":"20","author":"Qiu","year":"2016","unstructured":"14. Qiu W, Lv GY, Jiang C, et al. Successful salvage treatment of acute graft-versus-host disease after liver transplantation by withdrawal of immunosuppression: a case report. Korean J Hepatobiliary Pancreat Surg. 2016;20(1):38-43.","journal-title":"Korean J Hepatobiliary Pancreat Surg"},{"issue":"12","key":"ref14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1097\/TP.0b013e3181735407","article-title":"Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis","volume":"85","author":"Garcia Prado","year":"2008","unstructured":"15. Garcia Prado ME, Matia EC, Ciuro FP, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation. 2008;85(12):1849-1854.","journal-title":"Transplantation"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Singh N, Husain S; AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:228-241.","DOI":"10.1111\/ajt.12115"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64(2):433-485.","DOI":"10.1016\/j.jhep.2015.10.006"},{"issue":"4","key":"ref17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3892\/etm.2014.1850","article-title":"Graft versus host disease following liver transplantation: A case report","volume":"8","author":"Zhang","year":"2014","unstructured":"18. Zhang C, Yang G, Ling Y, Chen G, Zhou T. Graft versus host disease following liver transplantation: A case report. Exp Ther Med. 2014;8(4):1164-1166.","journal-title":"Exp Ther Med"},{"issue":"31","key":"ref18","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.3748\/wjg.v20.i31.10658","article-title":"Cytomegalovirus infection in liver transplant recipients: updates on clinical management","volume":"20","author":"Marcelin","year":"2014","unstructured":"19. Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: updates on clinical management. World J Gastroenterol. 2014;20(31):10658-10667.","journal-title":"World J Gastroenterol"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T08:28:04Z","timestamp":1584433684000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2020\/18\/1\/0\/123\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2017.0231","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}